Lipopolysaccharide-induced apoptosis in a murine intestinal endocrine cell line by modulation of Bcl-2, Bax and caspase-3

Molecular Medicine Reports

Volumn 8, Issue 6, 2013, Pages 1649-1654

  Lei, Lei ^a   Wang, Jiao ^a   Zhang, Zhen ^a   Zhang, Hua ^a   Chen, Hong ^a   Cai, Dehong ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Enteroendocrine L cells; Glucagon like peptide 1; Lipopolysaccharide

Indexed keywords

CASPASE 3; LIPOPOLYSACCHARIDE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CELL STRAIN STC 1; CELL VIABILITY; CONTROLLED STUDY; ENTEROENDOCRINE CELL; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; CELL LINE; CELL SHAPE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; ENDOCRINE CELL; INTESTINE; METABOLISM;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE; CELL SHAPE; CELL SURVIVAL; ENDOCRINE CELLS; FLOW CYTOMETRY; INTESTINES; LIPOPOLYSACCHARIDES; MICE;

EID: 84893757349     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1744     Document Type: Article

References (24)

1. Larsen N, Vogensen FK, van den Berg FW, et al: Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5: e9085, 2010.
2. Drucker DJ and Nauck MA: The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368: 1696-1705, 2006.
3. Toft-Nielsen MB, Damholt MB, Madsbad S, et al: Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 86: 3717-3723, 2001.
4. Vilsboll T, Krarup T, Deacon CF, Madsbad S and Holst JJ: Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50: 609-613, 2001.
5. Cani PD and Delzenne NM: Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care 10: 729-734, 2007.
6. Creely SJ, McTernan PG, Kusminski CM, et al: Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292: E740-E747, 2007.
7. Lü F, Jin T and Drucker DJ: Proglucagon gene expression is induced by gastrin-releasing peptide in a mouse enteroendocrine cell line. Endocrinology 137: 3710-3716, 1996.
8. Jin T and Drucker DJ: The proglucagon gene upstream enhancer contains positive and negative domains important for tissue-specific proglucagon gene transcription. Mol Endocrinol 9: 1306-1320, 1995.
9. Abello J, Ye F, Bosshard A, Bernard C, Cuber JC and Chayvialle JA: Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line. Endocrinology 134: 2011-2017, 1994.
10. Stoscheck CM: Quantitation of protein. Methods Enzymol 182: 50-68, 1990.
11. Alikhani M, Alikhani Z, He H, Liu R, Popek BI and Graves DT: Lipopolysaccharides indirectly stimulate apoptosis and global induction of apoptotic genes in fibroblasts. J Biol Chem 278: 52901-52908, 2003.
12. Xaus J, Comalada M, Valledor AF, et al: LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha. Blood 95: 3823-3831, 2000.
13. Hull C, McLean G, Wong F, Duriez PJ and Karsan A: Lipopolysaccharide signals an endothelial apoptosis pathway through TNF receptor-associated factor 6-mediated activation of c-Jun NH2-terminal kinase. J Immunol 169: 2611-2618, 2002.
14. Hamada E, Nishida T, Uchiyama Y, et al: Activation of Kupffer cells and caspase-3 involved in rat hepatocyte apoptosis induced by endotoxin. J Hepatol 30: 807-818, 1999.
15. Peter ME: Programmed cell death: Apoptosis meets necrosis. Nature 471: 310-312, 2011.
16. Bannerman DD and Goldblum SE: Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 284: L899-L914, 2003.
17. Huang YY, Peng CH, Yang YP, et al: Desipramine activated Bcl-2 expression and inhibited lipopolysaccharide-induced apoptosis in hippocampus-derived adult neural stem cells. J Pharmacol Sci 104: 61-72, 2007.
18. Youle RJ and Strasser A: The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59, 2008.
19. Tamm I, Schriever F and Dörken B: Apoptosis: implications of basic research for clinical oncology. Lancet Oncol 2: 33-42, 2001.
20. Salvesen GS: Caspases: opening the boxes and interpreting the arrows. Cell Death Differ 9: 3-5, 2002.
21. Ghavami S, Hashemi M, Ande SR, et al: Apoptosis and cancer: mutations within caspase genes. J Med Genet 46: 497-510, 2009.
22. Walters J, Pop C, Scott FL, et al: A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis. Biochem J 424: 335-345, 2009.
23. Deaciuc IV, Fortunato F, D'Souza NB, Hill DB, Schmidt J, Lee EY and McClain CJ: Modulation of caspase-3 activity and Fas ligand mRNA expression in rat liver cells in vivo by alcohol and lipopolysaccharide. Alcohol Clin Exp Res 23: 349-356, 1999.
24. Hord NG: Eukaryotic-microbiota crosstalk: potential mechanisms for health benefits of prebiotics and probiotics. Annu Rev Nutr 28: 215-231, 2008.